Editorial: CRISPR: the game changer in gene and cell therapy
2024

CRISPR: the game changer in gene and cell therapy

Editorial

Author Information

Author(s): He Wenxia, Bai Meizhu

Primary Institution: University of North Carolina, Chapel Hill, NC, United States

Conclusion

CRISPR technology has transformed gene and cell therapy, providing new possibilities for treating genetic disorders, cancer, and infectious diseases.

Supporting Evidence

  • CRISPR technology has reshaped genome engineering and therapy development.
  • CRISPR/Cas12a enhances precision in diagnostics.
  • Prime editing allows for precise genetic modifications without double-strand breaks.
  • CRISPR/Cas9 is widely used in disease modeling and therapy.
  • Advancements in delivery systems are crucial for CRISPR-based therapies.

Takeaway

CRISPR is like a pair of scissors for DNA that helps scientists fix genes to treat diseases. It's changing how we think about medicine.

Potential Biases

No financial support was declared, reducing potential bias.

Limitations

The editorial discusses challenges such as safety, efficacy, and ethical considerations in CRISPR technology.

Digital Object Identifier (DOI)

10.3389/fgene.2024.1517298

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication